ES2089664T3 - Composicion y metodo para conservar la sangre. - Google Patents

Composicion y metodo para conservar la sangre.

Info

Publication number
ES2089664T3
ES2089664T3 ES93115323T ES93115323T ES2089664T3 ES 2089664 T3 ES2089664 T3 ES 2089664T3 ES 93115323 T ES93115323 T ES 93115323T ES 93115323 T ES93115323 T ES 93115323T ES 2089664 T3 ES2089664 T3 ES 2089664T3
Authority
ES
Spain
Prior art keywords
blood
composition
preserve
conservation
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93115323T
Other languages
English (en)
Inventor
Kazumi Ogata
Kenichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2089664T3 publication Critical patent/ES2089664T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA COMPOSICION PARA CONSERVAR LA SANGRE QUE CONTIENE UN DIESTER DE ACIDO FOSFORICO DE LA FORMULA SIGUIENTE: (EN DONDE R1 Y R2 SON IGUALES O DIFERENTES Y CADA UNO REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO METILO) O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE LA MISMA Y UN METODO PARA LA CONSERVACION DE LA SANGRE QUE CONSISTE EN LA UTILIZACION DEL COMPUESTO. EL COMPUESTO UTILIZADO PARA LA COMPOSICION DE CONSERVACION DE LA SANGRE DE LA INVENCION ES CAPAZ DE MANTENER LA FUNCION BIOLOGICA DE LA SANGRE DURANTE UN LARGO PERIODO DE TIEMPO SIN DAÑAR LOS COMPONENTES. POR TANTO, LA COMPOSICION DE LA INVENCION SE PUEDE UTILIZAR VENTAJOSAMENTE PARA CONSERVAR LA SANGRE Y SUS COMPONENTES TALES COMO ERITROCITOS, LEUCOCITOS Y PLAQUETAS Y ES UTIL PARA PREVENIR LOS TRASTORNOS HEPATICOS QUE PUEDEN ACOMPAÑAR A UNA TRANSFUSION DE SANGRE.
ES93115323T 1992-09-30 1993-09-23 Composicion y metodo para conservar la sangre. Expired - Lifetime ES2089664T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26131192 1992-09-30

Publications (1)

Publication Number Publication Date
ES2089664T3 true ES2089664T3 (es) 1996-10-01

Family

ID=17360035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93115323T Expired - Lifetime ES2089664T3 (es) 1992-09-30 1993-09-23 Composicion y metodo para conservar la sangre.

Country Status (8)

Country Link
US (1) US5480773A (es)
EP (1) EP0590514B1 (es)
KR (1) KR100253819B1 (es)
AT (1) ATE139665T1 (es)
CA (1) CA2106558A1 (es)
DE (1) DE69303343T2 (es)
ES (1) ES2089664T3 (es)
TW (1) TW262386B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW254852B (es) * 1993-12-02 1995-08-21 Senju Pharma Co
JPH07215801A (ja) * 1994-01-28 1995-08-15 Senju Pharmaceut Co Ltd 肺保存剤および肺保存方法
JPH07330501A (ja) * 1994-06-14 1995-12-19 Senju Pharmaceut Co Ltd 肝保存剤および肝保存方法
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US6548241B1 (en) 2000-11-28 2003-04-15 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
WO2002049653A1 (en) * 2000-12-21 2002-06-27 Metabolic Engineering Laboratories Co., Ltd. Compositions for preservation of organs and blood
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
CN101919381B (zh) * 2010-09-06 2013-05-22 南方医科大学珠江医院 一种生物人工肝用肝细胞的保存液及其制备方法
AU2012240016B2 (en) 2011-04-07 2016-11-10 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
KR101426804B1 (ko) 2012-10-09 2014-08-05 김홍승 혈소판 보존 조성물, 이를 포함하는 혈소판 보존 키트 및 이를 이용한 혈소판 보존 방법
US10448631B2 (en) 2015-09-22 2019-10-22 East Carolina University Cryopreservation using sucralose

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
US4605644A (en) * 1985-02-07 1986-08-12 Regents Of The University Of Minnesota Method for stimulating recovery from ischemia employing ribose and adenine
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
US4880786A (en) * 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4994444A (en) * 1987-07-31 1991-02-19 The Trustees Of Columbia In The City Of New York Macromolecules for sealing capillary endothelial junctions
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US5037419A (en) * 1989-09-21 1991-08-06 Eastman Kodak Company Blood bag system containing vitamin E
JPH0499772A (ja) * 1990-08-17 1992-03-31 Kanebo Ltd トコフェロール―５，６―０―イソプロピリデン―ｌ―アスコルビン酸―２―ジカルボン酸ジエステル，及びその製造方法，並びにそれより成るビタミンｃ・ビタミンｅ補給剤

Also Published As

Publication number Publication date
ATE139665T1 (de) 1996-07-15
DE69303343T2 (de) 1996-12-05
DE69303343D1 (de) 1996-08-01
KR940006582A (ko) 1994-04-25
EP0590514A1 (en) 1994-04-06
TW262386B (es) 1995-11-11
US5480773A (en) 1996-01-02
CA2106558A1 (en) 1994-03-31
EP0590514B1 (en) 1996-06-26
KR100253819B1 (ko) 2000-07-01

Similar Documents

Publication Publication Date Title
ES2089664T3 (es) Composicion y metodo para conservar la sangre.
IT1135257B (it) Soluzione per la conservazione di cellule rosse
ES2145864T3 (es) Utilizacion de acido d,l-alfa-lipoico, sus enantiomeros y/o derivados como aditivo en conservas liquidas de eritrocitos y crioconservas para concentrados homologos y antologos de eritrocitos.
ES2032899T3 (es) Agente cosmetico para aplicacion externa y su uso.
ES8301029A1 (es) Procedimiento para la preparacion de un agente de valoracion
ES2015011B3 (es) Esteres de acido acrilico sustituido y fungicidas que contienen estos compuestos.
BE605871A (fr) Procédé de préparation de concentrés liquides stables à l'entreposage contenant de l'oxygène actif
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
DE3752307D1 (de) Verfahren zum Sammeln von Insekten-Körperflussigkeiten
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES2019282B3 (es) Derivados del acido acrilico y fungicidas que contienen estos compuestos.
ES8800254A1 (es) Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib.
ES2062268T3 (es) Esteres del acido tiolcarboxilico y fungicidas que les contienen.
ATE35292T1 (de) Extraktionsverfahren zur selektiven entfernung von kobalt(ii) aus waessrigen loesungen.
ES8706371A1 (es) Procedimiento para preparar derivados de tetrazol con actividad insecticida
ES8705224A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
ATE79755T1 (de) N-(2-carboxy)-ethyl-1,8-naphthalenimid und dessen salze zur behandlung von diabetischen retinopathien und neuropathien.
ES8708139A1 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES8300741A1 (es) Un procedimiento para la preparacion de tiofen-sulfonamidas con actividad insecticida.
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES8308551A1 (es) Procedimiento para la preparacion de derivados de tiazolina.
ES2044241T3 (es) Procedimiento para la obtencion de esteres del acido acrilico y fungicidas que les contienen.
BE877050A (fr) Utilisation d'esters d'acides hydroxycarboxyliques aliphatiques en tant que desodorisants
ES8307255A1 (es) Procedimiento para preparar derivados de cefalosporina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 590514

Country of ref document: ES

FG2A Definitive protection

Ref document number: 590514

Country of ref document: ES